FDA Reform Bill May Be Delayed Until September; FDA Holds Tight On Staffing Issues
This article was originally published in The Pink Sheet Daily
Executive Summary
Reauthorization of prescription drug user fees will go down to the wire as health leaders in House and Senate devote attention to child health legislation.
You may also be interested in...
Von Eschenbach Holds FDA RIFs At Bay With Reserve Fund, But Staff Stability Remains A Concern
PDUFA carry over funds enable FDA to avoid reduction-in-force process.
Von Eschenbach Holds FDA RIFs At Bay With Reserve Fund, But Staff Stability Remains A Concern
PDUFA carry over funds enable FDA to avoid reduction-in-force process.
Part D Formulary Changes Would Permit Enrollees To Switch Medicare Plans Mid-Year, Under House Child Health Bill
Medicare provisions in bill slated for July 26 markup include making six “protected” formulary classes permanent and requiring that dual eligibles be assigned to plans covering the most common brand and generic products.